4-Antibody AG

https://www.4-antibody.com

4-Antibody is a biopharmaceutical company with a powerful fully-human antibody drug-discovery technology platform which is generating an emerging pipeline of antibody therapeutics. The proprietary discovery engine is the in vitro Retrocyte Display® technology, a fast and highly efficient source of antibody drug candidates. Retrocyte Display® generates high quality therapeutic antibody drug candidates quickly using a rapid, high-throughput, flow cytometry approach incorporating fulllength IgG format human antibody libraries expressed in mammalian B cells. 4-Antibody provides access to its technologies to select pharmaceutical R&D collaborators and is also generating an inhouse pipeline of antibody drugs. The Company's lead development product is an anticytomegalovirus antibody drug. 4-Antibody is a private company with strong, commerciallyexperienced leadership located in Basel, Switzerland and Jena, Germany. *

	Start	2002-01-01 splitoff
	Group	Agenus (Group)
	Predecessor	University of Basel
	Industry	therapeutic antibody
	Industry 2	Retrocyte Display® technology
	Person	Burns, Robert F. (4-Antibody 201101– CEO before Affitech CEO before Celldex Therapeutics CEO)

	Region	Basel BS
	Country	Switzerland
	Street	60c Hochbergerstr.
	City	4057 Basel BS
	Tel	+41-61-633-2260
		Address record changed: 2020-12-02

Basic data	Employees	B: 11 to 50 (2008-10-01)

		* Document for »About Section«:

		Record changed: 2023-07-10